Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis

oleh: Yin Yang, Jianyang Wang, Wenqing Wang, Tao Zhang, Jingjing Zhao, Yu Wang, Yexiong Li, Luhua Wang, Nan Bi

Format: Article
Diterbitkan: Frontiers Media S.A. 2022-08-01

Deskripsi

Subjek

Limited-stage small-cell lung cancer; surrogate endpoint; overall survival; progression-free survival; time to progression; chemoradiotherapy